Clinical effect evaluation of Guben Qushi Prescription in treating dampness of spleen deficiency eczema
- Conditions
- Eczema
- Registration Number
- ITMCTR2200006104
- Lead Sponsor
- The Second Affiliated Hospital of Guangzhou University of Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- Not specified
(1) Meet the diagnostic criteria of Western medicine for eczema;
(2) Conforms to the diagnostic criteria of spleen deficiency and dampness accumulation syndrome of TRADITIONAL Chinese medicine (determined by combining the industry standards of TRADITIONAL Chinese medicine and the preliminary research results of the research group);
(3) Age: 18-65;
(4) 7 < eczema area and severity index (EASI) =21;
(5) skin area =3% (3% is equivalent to 3 palm area);
(6) Voluntarily participate in the study and sign the informed consent.
(1) Patients with abnormal blood system, liver, kidney, heart and other systems;
(2) patients suffering from mental diseases, malignant tumors, diabetes and heart disease, and pregnant and lactating women;
(3) with other skin diseases;
(4) Systematic use of glucocorticoids or immunosuppressants (including Tripterygium wilfordii) in the last 4 weeks;
(5) known allergic to test drug components.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method EASI(Eczema area and severity index);
- Secondary Outcome Measures
Name Time Method VAS(Visual Analog Scale);DLQI(dermatology life quality index);POEM(Patient Oriented Eczema Measure);